Our Pipeline

Direct Biologics is committed to advancing patient care through rigorous clinical research. Our team designs and conducts clinical trials with a focus on patient safety, scientific integrity, and ethical standards. Direct Biologics is developing investigational secretome-based products for serious conditions with unmet needs, including Acute Respiratory Distress Syndrome (ARDS) and Perianal Fistulizing Crohn’s Disease. These investigational products are manufactured under cGMP standards and are being evaluated in clinical trials conducted under active Investigational New Drug applications. All Direct Biologics programs are investigational and have not been approved by the U.S. Food and Drug Administration.